SynteractHCR expands in adaptive trials; Cobra partners with Recopharma;

> SynteractHCR has expanded its adaptive trials capabilities, allowing clients to adjust study parameters without sullying results. More

> Cobra Biologics has signed a deal to supply proteins for human cell lines to Recopharma. News

> German CRO ICRC-Weyer has added drug safety services to its platform of clinical research. Item

> Australia's Novotech has expanded its partnership with Medidata Solutions, using the company's software for trial data management and randomization. Story

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.